Generation Bio Co. Common Stock (GBIO)
Generation Bio Co. (GBIO) is a biotech company focused on developing gene therapy solutions for genetic diseases. Using their proprietary non-viral delivery platform, they aim to develop durable and safe treatments for patients with serious unmet medical needs.
Company News
Generation Bio, a biotechnology company, announced that its president and CEO will participate in a fireside chat at the Canaccord Genuity 44th Annual Growth Conference on August 13th, 2024.
Generation Bio (GBIO) delivered earnings and revenue surprises of -211.11% and 34.63%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
3 top penny stocks to watch with insider buying this month. The post 3 Penny Stocks To Buy According To Insiders In December appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Shares of Wynn Resorts, Limited (NASDAQ: WYNN) fell sharply on Friday after the company reported third-quarter financial results. Wynn Resorts reported third quarter operating revenue of $1.67 billion, which was up from a total of $889.7 million reported in the prior year's period. The revenue total beat a Street consensus estimate of $1.585 bill...